Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)

Ji, LN; Wan, HL; Wen, BH; Wang, XY; Wang, JF; Bian, RW; Pang, WY; Tian, J; Wang, Y; Bian, F; Gao, ZN; Condoleon, A; Feng, W; Zhang, X; Cui, N

Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, 11 Xizhimen South St, Beijing 100044, Peoples R China.

DIABETES OBESITY & METABOLISM, 2020; 22 (5): 838

Abstract

Aim To determine the safety of a higher starting dose of basal insulin in overweight/obese patients with type 2 diabetes (T2D). Materials and methods ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索